AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- Hologic, Inc., (HOLX) announced receipt of marketing clearance from the U.S. Food and Drug Administration (FDA) for its SecurViewDX breast imaging workstation.
The SecurViewDX is a dedicated, multi-modality workstation for display and interpretation of any screening or diagnostic digital mammogram, as well as other images, such as magnetic resonance imaging, computed tomography, positron emission tomography, and ultrasound.
The workstation will also support digital computer aided detection (CAD) programs.
"This is an important milestone in Hologic's breast imaging development program," said Jack W. Cumming, Hologic's chairman and chief executive officer. "The ability to use our dedicated workstation to view digital mammograms from any vendor, as well as images from other modalities, should have a significant impact on improved workflow in breast imaging suites.
"In addition, physicians will now be able to use our package of highly specialized image manipulation tools on virtually any digital mammogram. These tools have been developed in close cooperation with ...
Source: HighBeam Research, SecurViewDX breast imaging workstation receives FDA clearance.